soul trial oral semaglutide cardiovascular outcomes 2024 results nejm 2025 The (Semaglutide Trial) was a randomized ADA 2025: Oral Semaglutide soul trial oral semaglutide cardiovascular

doi: 10.1172/JCI104891 62 MalekASagerRZakherASchneiderH

And the outcomes remain to be determined

This is an observed phenomenon where the peptides ability to accelerate cell turnover brings underlying congestion (such as microcomedones or trapped sebum) to the surface more quickly

Sulfur burps specifically are not usually broken out as their own category in clinical trials, which track broader headings like belching, dyspepsia, bloating, and nausea

Micutkova et al., 2011), further mitigating the chronic inflammation that drives fibrosis

It's important to follow your doctor's guidance and stay consistent with your treatment plan to achieve the best results